61755-005-01 |
61755-005 |
HUMAN PRESCRIPTION DRUG |
EYLEA |
aflibercept |
INJECTION, SOLUTION |
INTRAVITREAL |
20191209 |
N/A |
BLA |
BLA125387 |
Regeneron Pharmaceuticals, Inc. |
AFLIBERCEPT |
40 mg/mL |
1 SYRINGE, GLASS in 1 CARTON (61755-005-01) / .05 mL in 1 SYRINGE, GLASS |
61755-005-02 |
61755-005 |
HUMAN PRESCRIPTION DRUG |
EYLEA |
aflibercept |
INJECTION, SOLUTION |
INTRAVITREAL |
20111121 |
N/A |
BLA |
BLA125387 |
Regeneron Pharmaceuticals, Inc. |
AFLIBERCEPT |
40 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) / .05 mL in 1 VIAL, SINGLE-USE |
61755-005-54 |
61755-005 |
HUMAN PRESCRIPTION DRUG |
EYLEA |
aflibercept |
INJECTION, SOLUTION |
INTRAVITREAL |
20191209 |
N/A |
BLA |
BLA125387 |
Regeneron Pharmaceuticals, Inc. |
AFLIBERCEPT |
40 mg/mL |
1 SYRINGE, GLASS in 1 CARTON (61755-005-54) / .05 mL in 1 SYRINGE, GLASS |
61755-005-55 |
61755-005 |
HUMAN PRESCRIPTION DRUG |
EYLEA |
aflibercept |
INJECTION, SOLUTION |
INTRAVITREAL |
20140116 |
N/A |
BLA |
BLA125387 |
Regeneron Pharmaceuticals, Inc. |
AFLIBERCEPT |
40 mg/mL |
1 VIAL, SINGLE-USE in 1 CARTON (61755-005-55) / .05 mL in 1 VIAL, SINGLE-USE |